China RNAi for Therapeutic Market Research Report 2016

China RNAi for Therapeutic Market Research Report 2016

1 RNAi for Therapeutic Market Overview

1.1 Product Overview and Scope of RNAi for Therapeutic

1.2 RNAi for Therapeutic Segment by Type

1.2.1 China Production Market Share of RNAi for Therapeutic Type in 2015

1.2.2 siRNA

1.2.3 miRNA

1.2.4 shRNA

1.3 Applications of RNAi for Therapeutic

1.3.1 RNAi for Therapeutic Consumption Market Share by Application in 2015

1.3.2 Cancer

1.3.3 Cardiovascular

1.3.4 HBV

1.4 China Market Size (Value) of RNAi for Therapeutic (2011-2021)

1.5 China RNAi for TherapeuticStatus and Outlook

1.6 Government Policies

2 China RNAi for Therapeutic Market Competition by Manufacturers

2.1 China RNAi for Therapeutic Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China RNAi for Therapeutic Revenue and Share by Manufacturers (2015 and 2016)

2.3 China RNAi for Therapeutic Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers RNAi for Therapeutic Manufacturing Base Distribution, Sales Area, Product Type

2.5 RNAi for Therapeutic Market Competitive Situation and Trends

2.5.1 RNAi for Therapeutic Market Concentration Rate

2.5.2 RNAi for Therapeutic Market Share of Top 3 and Top 5 Manufacturers

3 China RNAi for Therapeutic Manufacturers Profiles/Analysis

3.1 Alnylam Pharmaceuticals

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 RNAi for Therapeutic Product Type, Application and Specification

3.1.2.1 Type I

3.1.2.2 Type II

3.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 Arbutus Biopharma (Tekmira)

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 118 Product Type, Application and Specification

3.2.2.1 Type I

3.2.2.2 Type II

3.2.3 Arbutus Biopharma (Tekmira) 118 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 Arrowhead Research

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 129 Product Type, Application and Specification

3.3.2.1 Type I

3.3.2.2 Type II

3.3.3 Arrowhead Research 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 Dicerna Pharmaceuticals

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Oct Product Type, Application and Specification

3.4.2.1 Type I

3.4.2.2 Type II

3.4.3 Dicerna Pharmaceuticals Oct Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Mirna Therapeutics

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Product Type, Application and Specification

3.5.2.1 Type I

3.5.2.2 Type II

3.5.3 Mirna Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 Quark Pharmaceuticals

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Million USD Product Type, Application and Specification

3.6.2.1 Type I

3.6.2.2 Type II

3.6.3 Quark Pharmaceuticals Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 RXi Pharmaceuticals

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Medical Devices Product Type, Application and Specification

3.7.2.1 Type I

3.7.2.2 Type II

3.7.3 RXi Pharmaceuticals Medical Devices Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 Silence Therapeutics

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Product Type, Application and Specification

3.8.2.1 Type I

3.8.2.2 Type II

3.8.3 Silence Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

3.9 Benitec Biopharma

3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.9.2 Product Type, Application and Specification

3.9.2.1 Type I

3.9.2.2 Type II

3.9.3 Benitec Biopharma Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.9.4 Main Business/Business Overview

3.10 Miragen Therapeutics

3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.10.2 Product Type, Application and Specification

3.10.2.1 Type I

3.10.2.2 Type II

3.10.3 Miragen Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.10.4 Main Business/Business Overview

3.11 Sylentis

3.12 Gradalis

3.13 Sirnaomics

3.14 Silenseed

4 China RNAi for Therapeutic Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)

4.1 China RNAi for Therapeutic Capacity, Production and Growth (2011-2016)

4.2 China RNAi for Therapeutic Revenue and Growth (2011-2016)

4.3 China RNAi for Therapeutic Production, Consumption, Export and Import (2011-2016)

5 China RNAi for Therapeutic Production, Revenue (Value), Price Trend by Type

5.1 China RNAi for Therapeutic Production and Market Share by Type (2011-2016)

5.2 China RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)

5.3 China RNAi for Therapeutic Price by Type (2011-2016)

5.4 China RNAi for Therapeutic Production Growth by Type (2011-2016)

6 China RNAi for Therapeutic Market Analysis by Application

6.1 China RNAi for Therapeutic Consumption and Market Share by Application (2011-2016)

6.2 China RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 RNAi for Therapeutic Manufacturing Cost Analysis

7.1 RNAi for Therapeutic Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of RNAi for Therapeutic

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 RNAi for Therapeutic Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China RNAi for Therapeutic Market Forecast (2016-2021)

11.1 China RNAi for Therapeutic Capacity, Production, Revenue Forecast (2016-2021)

11.2 China RNAi for Therapeutic Production, Import, Export and Consumption Forecast (2016-2021)

11.3 China RNAi for Therapeutic Production Forecast by Type (2016-2021)

11.4 China RNAi for Therapeutic Consumption Forecast by Application (2016-2021)

11.5 RNAi for Therapeutic Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of RNAi for Therapeutic

Figure China Production Market Share of RNAi for Therapeutic by Type in 2015

Figure Product Picture of siRNA

Table Major Manufacturers of siRNA

Figure Product Picture of miRNA

Table Major Manufacturers of miRNA

Figure Product Picture of shRNA

Table Major Manufacturers of shRNA

Table RNAi for Therapeutic Consumption Market Share by Application in 2015

Figure Cancer Examples

Figure Cardiovascular Examples

Figure HBV Examples

Figure China RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)

Table China RNAi for Therapeutic Capacity of Key Manufacturers (2015 and 2016)

Table China RNAi for Therapeutic Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China RNAi for Therapeutic Capacity of Key Manufacturers in 2015

Figure China RNAi for Therapeutic Capacity of Key Manufacturers in 2016

Table China RNAi for Therapeutic Production of Key Manufacturers (2015 and 2016)

Table China RNAi for Therapeutic Production Share by Manufacturers (2015 and 2016)

Figure 2015 RNAi for Therapeutic Production Share by Manufacturers

Figure 2016 RNAi for Therapeutic Production Share by Manufacturers

Table China RNAi for Therapeutic Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China RNAi for Therapeutic Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China RNAi for Therapeutic Revenue Share by Manufacturers

Table 2016 China RNAi for Therapeutic Revenue Share by Manufacturers

Table China Market RNAi for Therapeutic Average Price of Key Manufacturers (2015 and 2016)

Figure China Market RNAi for Therapeutic Average Price of Key Manufacturers in 2015

Table Manufacturers RNAi for Therapeutic Manufacturing Base Distribution and Sales Area

Table Manufacturers RNAi for Therapeutic Product Type

Figure RNAi for Therapeutic Market Share of Top 3 Manufacturers

Figure RNAi for Therapeutic Market Share of Top 5 Manufacturers

Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Alnylam Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)

Table Arbutus Biopharma (Tekmira) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Market Share (2011-2016)

Table Arrowhead Research Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Arrowhead Research RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Arrowhead Research RNAi for Therapeutic Market Share (2011-2016)

Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Dicerna Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)

Table Mirna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Mirna Therapeutics RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2011-2016)

Table Quark Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Quark Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)

Table RXi Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table RXi Pharmaceuticals RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)

Table Silence Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Silence Therapeutics RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Silence Therapeutics RNAi for Therapeutic Market Share (2011-2016)

Table Benitec Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Benitec Biopharma RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Benitec Biopharma RNAi for Therapeutic Market Share (2011-2016)

Table Miragen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Miragen Therapeutics RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Miragen Therapeutics RNAi for Therapeutic Market Share (2011-2016)

Table Sylentis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sylentis RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Sylentis RNAi for Therapeutic Market Share (2011-2016)

Table Gradalis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Gradalis RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Gradalis RNAi for Therapeutic Market Share (2011-2016)

Table Sirnaomics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sirnaomics RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Sirnaomics RNAi for Therapeutic Market Share (2011-2016)

Table Silenseed Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Silenseed RNAi for Therapeutic Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Silenseed RNAi for Therapeutic Market Share (2011-2016)

Figure China RNAi for Therapeutic Capacity, Production and Growth (2011-2016)

Figure China RNAi for Therapeutic Revenue (Million USD) and Growth (2011-2016)

Table China RNAi for Therapeutic Production, Consumption, Export and Import (2011-2016)

Table China RNAi for Therapeutic Production by Type (2011-2016)

Table China RNAi for Therapeutic Production Share by Type (2011-2016)

Figure Production Market Share of RNAi for Therapeutic by Type (2011-2016)

Figure 2015 Production Market Share of RNAi for Therapeutic by Type

Table China RNAi for Therapeutic Revenue by Type (2011-2016)

Table China RNAi for Therapeutic Revenue Share by Type (2011-2016)

Figure Production Revenue Share of RNAi for Therapeutic by Type (2011-2016)

Figure 2015 Revenue Market Share of RNAi for Therapeutic by Type

Table China RNAi for Therapeutic Price by Type (2011-2016)

Figure China RNAi for Therapeutic Production Growth by Type (2011-2016)

Table China RNAi for Therapeutic Consumption by Application (2011-2016)

Table China RNAi for Therapeutic Consumption Market Share by Application (2011-2016)

Figure China RNAi for Therapeutic Consumption Market Share by Application in 2015

Table China RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)

Figure China RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of RNAi for Therapeutic

Figure Manufacturing Process Analysis of RNAi for Therapeutic

Figure RNAi for Therapeutic Industrial Chain Analysis

Table Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015

Table Major Buyers of RNAi for Therapeutic

Table Distributors/Traders List

Figure China RNAi for Therapeutic Capacity, Production and Growth Rate Forecast (2016-2021)

Figure China RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)

Table China RNAi for Therapeutic Production, Import, Export and Consumption Forecast (2016-2021)

Table China RNAi for Therapeutic Production Forecast by Type (2016-2021)

Table China RNAi for Therapeutic Consumption Forecast by Application (2016-2021)